These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 29154107)

  • 1. Aripiprazole in treatment of Gilles de la Tourette syndrome - New therapeutic option.
    Janik P; Szejko N
    Neurol Neurochir Pol; 2018; 52(1):84-87. PubMed ID: 29154107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aripiprazole in the pharmacotherapy of Gilles de la Tourette syndrome in adult patients.
    Kawohl W; Schneider F; Vernaleken I; Neuner I
    World J Biol Psychiatry; 2009; 10(4 Pt 3):827-31. PubMed ID: 18843565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabis-based medicine in treatment of patients with Gilles de la Tourette syndrome.
    Szejko N; Saramak K; Lombroso A; Müller-Vahl K
    Neurol Neurochir Pol; 2022; 56(1):28-38. PubMed ID: 34708399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aripiprazole Improves Associated Comorbid Conditions in Addition to Tics in Adult Patients with Gilles de la Tourette Syndrome.
    Gerasch S; Kanaan AS; Jakubovski E; Müller-Vahl KR
    Front Neurosci; 2016; 10():416. PubMed ID: 27672358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of m-CPP on tics and obsessive-compulsive phenomena in Gilles de la Tourette syndrome.
    Cath DC; Gijsman HJ; Schoemaker RC; van Griensven JM; Troost N; van Kempen GM; Cohen AF
    Psychopharmacology (Berl); 1999 May; 144(2):137-43. PubMed ID: 10394994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A controlled study of sensory tics in Gilles de 1a Tourette syndrome and obsessive-compulsive disorder using a structured interview.
    Chee KY; Sachdev P
    J Neurol Neurosurg Psychiatry; 1997 Feb; 62(2):188-92. PubMed ID: 9048721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olanzapine in Gilles de la Tourette syndrome: beyond tics.
    Van den Eynde F; Naudts KH; De Saedeleer S; van Heeringen C; Audenaert K
    Acta Neurol Belg; 2005 Dec; 105(4):206-11. PubMed ID: 16482870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aripiprazole for the treatment of Tourette syndrome.
    Cox JH; Cavanna AE
    Expert Rev Neurother; 2021 Apr; 21(4):381-391. PubMed ID: 33612035
    [No Abstract]   [Full Text] [Related]  

  • 9. [Multiple tics and Gilles de la Tourette syndrome].
    Müller K
    Monatsschr Kinderheilkd; 1991 Jun; 139(6):330-5. PubMed ID: 1680219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of Gilles de la Tourette syndrome and other chronic tic disorders on quality of life across the lifespan: a systematic review.
    Evans J; Seri S; Cavanna AE
    Eur Child Adolesc Psychiatry; 2016 Sep; 25(9):939-48. PubMed ID: 26880181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperkinetic movement disorders misdiagnosed as tics in Gilles de la Tourette syndrome.
    Kompoliti K; Goetz CG
    Mov Disord; 1998 May; 13(3):477-80. PubMed ID: 9613740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dystonic tics in patients with Gilles de la Tourette syndrome.
    Szejko N; Jakubczyk A; Dunalska A; Janik P
    Neurol Neurochir Pol; 2019; 53(5):335-340. PubMed ID: 31621889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reflex tics in two patients with Gilles de la Tourette syndrome.
    Commander M; Corbett J; Prendergast M; Ridley C
    Br J Psychiatry; 1991 Dec; 159():877-9. PubMed ID: 1790463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reinforcement learning and Gilles de la Tourette syndrome: dissociation of clinical phenotypes and pharmacological treatments.
    Worbe Y; Palminteri S; Hartmann A; Vidailhet M; Lehéricy S; Pessiglione M
    Arch Gen Psychiatry; 2011 Dec; 68(12):1257-66. PubMed ID: 22147843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tics and Gilles de la Tourette disease].
    Dordain G
    Rev Prat; 1997 May; 47(10):1094-7. PubMed ID: 9208673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gilles de la Tourette syndrome - A treatable condition?
    Hartmann A; Martino D; Murphy T
    Rev Neurol (Paris); 2016; 172(8-9):446-454. PubMed ID: 27476415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eye signs and tic disorders: Gilles de la Tourette's syndrome.
    Goetz CG
    J Am Optom Assoc; 1997 Nov; 68(11):688-92. PubMed ID: 9409103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urge-tic associations in children and adolescents with Tourette syndrome.
    Langelage J; Verrel J; Friedrich J; Siekmann A; Schappert R; Bluschke A; Roessner V; Paulus T; Bäumer T; Frings C; Beste C; Münchau A
    Sci Rep; 2022 Sep; 12(1):16008. PubMed ID: 36163482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct structural changes underpin clinical phenotypes in patients with Gilles de la Tourette syndrome.
    Worbe Y; Gerardin E; Hartmann A; Valabrégue R; Chupin M; Tremblay L; Vidailhet M; Colliot O; Lehéricy S
    Brain; 2010 Dec; 133(Pt 12):3649-60. PubMed ID: 20959309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health-related quality of life, anxiety and depression in parents of adolescents with Gilles de la Tourette syndrome: a controlled study.
    Jalenques I; Auclair C; Morand D; Legrand G; Marcheix M; Ramanoel C; Hartmann A; ; Derost P
    Eur Child Adolesc Psychiatry; 2017 May; 26(5):603-617. PubMed ID: 27942998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.